MDL-811 suppressed CRC proliferation synergistically with vitamin D3, which is both a substrate and transcriptional regulator of CYP24A1 and had previously shown anti-tumor efficacy in CRC [112,113]. The gene discussed is CYP24A1; the disease is colorectal carcinoma.